New Vaccine Could Aid in Battle Against Cocaine Addiction
A new animal study shows promise for development of a vaccine to be used for the treatment of cocaine addiction. Researchers have developed a potentially revolutionary vaccine that could aid in helping cocaine addicts overcome their addiction.
Developed at New York-Presbyterian/Weill Cornell Medical Center, the vaccine has now been approved for clinical trials following experiments on animals. Testing showed the drug kept cocaine that had entered the bloodstream from reaching the brain.
Currently, there are drugs such as methadone which are designed to treat heroin addiction but there aren’t any available for treatment of cocaine addiction. Researchers are hoping that this vaccine will change that.
The vaccine, named dAdGNE, would work to protect cocaine from entering the brain. It would work as a blocker, which would prevent the drug’s passage to the brain and nervous system, resulting in curbing the dopamine-induced high, thus removing the craving for the drug.
In 2014 it was estimated that there were 1.5 million current cocaine users aged 12 and older in the United States.
The federal government has given approval for the trail on humans to begin. This vaccine could prove to be an extremely important tool in the battle against cocaine addiction should it become available to the public.